알츠하이머병, 파킨슨병 및 혈관성치매 환자들의 우울증에 대한 약물 치료 평가
Evaluation of Pharmacotherapy for the Patients with Depression in Alzheimer's Disease, Parkinson's Disease or Vascular Dementia
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Prevalence of depression comorbid with neurologic disorders such as Alzheimer' disease (AD), Parkinson's disease (PD) and vascular dementia (VD) is higher than that of primary depression. Antidepressant medications, suggested disease (PD) and vascular dementia (VD) is higher than that of primary depression. Antidepressant medications, suggested by many researches for depression comorbid with neurologic disorders such as AD, PD and VD, are mainly selective serotonin reuptake inhibitors (SSRI). Objective: The primary objective of this study is the evaluation of antidepressant drug therapy for AD, PD and VD. Method: This study was a retrospective study based on medical records, carried out for 3 years and 6 months (Jan. 2007~Jul. 2010). Patients, diagnosed as comorbid depression through Beck Depression Inventory (BDI), Cornell Depression Scale (CDS), Geriatric Depression Scale (GDS) among neurologic out-patients of Chungnam National University Hospital because of AD, PD and VD, were selected. The results were evaluated by efficacy and safety of antidepressant drug therapy. Results: In result, the prescribing rates of antidepressants were 30%, 55% and 40% for each AD, PD and VD. Depression cure rates of patients receiving antidepressants vs patients not receiving antidepressants were 40% vs 39%, 33% vs 23% and 38% vs 30% for AD, PD and VD. The frequencies of prescriptoin of SSRI were 21%, 11% and 27% for each AD, PD and VD. The frequencies of prescriptoin of benzodiazepine (BZD) was 61%, 82% and 61% for each AD, PD and VD. The ratio of single BZD prescription was more than that of combination prescription of antidepressants. Tricyclic antidepressants (TCA) were rarely prescribed. The rate of patients with BZD-related side effects was 54%. The most frequent side effects of BZD were dizziness (30%), drowsiness (21%) and headache (16%). disorders such as AD, PD and VD.
Abstract
Background: Prevalence of depression comorbid with neurologic disorders such as Alzheimer' disease (AD), Parkinson's disease (PD) and vascular dementia (VD) is higher than that of primary depression. Antidepressant medications, suggested disease (PD) and vascular dementia (VD) is higher than that of primary depression. Antidepressant medications, suggested by many researches for depression comorbid with neurologic disorders such as AD, PD and VD, are mainly selective serotonin reuptake inhibitors (SSRI). Objective: The primary objective of this study is the evaluation of antidepressant drug therapy for AD, PD and VD. Method: This study was a retrospective study based on medical records, carried out for 3 years and 6 months (Jan. 2007~Jul. 2010). Patients, diagnosed as comorbid depression through Beck Depression Inventory (BDI), Cornell Depression Scale (CDS), Geriatric Depression Scale (GDS) among neurologic out-patients of Chungnam National University Hospital because of AD, PD and VD, were selected. The results were evaluated by efficacy and safety of antidepressant drug therapy. Results: In result, the prescribing rates of antidepressants were 30%, 55% and 40% for each AD, PD and VD. Depression cure rates of patients receiving antidepressants vs patients not receiving antidepressants were 40% vs 39%, 33% vs 23% and 38% vs 30% for AD, PD and VD. The frequencies of prescriptoin of SSRI were 21%, 11% and 27% for each AD, PD and VD. The frequencies of prescriptoin of benzodiazepine (BZD) was 61%, 82% and 61% for each AD, PD and VD. The ratio of single BZD prescription was more than that of combination prescription of antidepressants. Tricyclic antidepressants (TCA) were rarely prescribed. The rate of patients with BZD-related side effects was 54%. The most frequent side effects of BZD were dizziness (30%), drowsiness (21%) and headache (16%). disorders such as AD, PD and VD.
참고문헌 (25)
- 이민식, "우울증과 자살", 247, pp.39~40 (2000), 현대사회문화연구소
- Murray AR, "Diagnosis and Treatment of Depression Comorbid with Neurologic Disorders", The American Journal of Medicine, 121, pp.S28~37 (2008)
- Lyketos CG, "Depression in Alzheimer's Disease: Overview and Treatment", pp.243~252 (2002), Society of Biological Psychiatry
- Brandt-Christensen M, "Parkinson’s disease and antidepressant drug treatment-A case-register Study", Parkinsonism and Related Disorders, 13, pp.406~410 (2007)
- 오병훈, "치매의 행동•정신 증상 진단 및 관리", 대한의사협회지, 52(11), pp.1048~1054 (2009), 대한의사협회
- Riedel O, "Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson’s disease", Journal of Neurology, 257, pp.1073~1082 (2010)
- 고성범, "우울증을 보인 급성 뇌졸중 환자의임상적 특징", 대한신경과학회지, 14(2), pp.359~370 (1996)
- 김영성, "노인 우울증에 있어서 약물 치료의 Guideline", 가정의학회지, 25(11), pp.S514~518 (2004)
- 민성길, "파킨슨 환자에서 보는 우울증", Journal of Korean Neuropsychiatry Association, 32(2), pp.188~194 (1993)
- 이준홍, "특발성 파킨슨증에서 우울증의빈도와 그에 영향을 미치는 임상요소들", 대한신경과학회지, 13(3), pp.574~583 (1995)
- Kanner AM, "Should neurologists be trained to recognize and treat comorbid depression of neurologic disorders? Yes", Epilepsy & Behavior, 6, pp.303~331 (2005)
- Meco G, "Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease", Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31, pp.311~313 (2007)
- Beck AT, "An inventory for measuring depression", Arch Gen Psychiatry, 4, pp.561~571 (1961)
- Yesavage JA, "Development and Validation of a Geriatric Depression Screening Scale. A Preliminary Report", Journal of Psychiatric Research, 17(1), pp.37~49 (1982)
- Alexopoulos GS, "Cornell Scale for Depression in dementia", Biological Psychiatry, 23, pp.271~284 (1998)
- Pei-Hao Chen, "Depression in Parkinson Disease: Current Understanding and Treatment", International Jeornal of Gerontology, 2(4), pp.172~182 (2008)
- McDonald WM, "Prevalence, Etiology, and Treatment of Depression in Parkinson’s Disease", Biological Psychiatry, 54, pp.363~375 (2003)
- Sawabini KA, "Treatment of depression in Parkinson's disease", Parkinsonism and Related Disorders, 10, pp.S37~41 (2004)
- Riedel O, "Frequency and treatment of depressive symptoms in a Parkinson's disease registry", Parkinsonism and Related Disorders, 14, pp.626~632 (2008)
- 이민수, "우울증의 약물요법", 대한의사협회지, 46(1), pp.69~75 (2003)
- Sontheimer DL, "Is imipramine or buspirone treatment effective in patients wishing to discontinue longterm benzodiazepine use?", Journal of Fam Pract, 50(3), pp.203~ (2001)
- Blier P, "Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant esponse", Neuropsychopharmacology, 16(5), pp.333~338 (1997)
- 정새진, "한국인들의 항우울제에 대한 인식 및 태도에 관한 연구", 한국임상약학회지, 22(1), pp.65~72 (2012), 한국임상약학회
- 황경미, "성인 정신질환 치료 약물", 병원약사회지, 25(1), pp.71~80 (2008)
- 김승현, "노년기 우울증의 치료전략", 대한정신약물학회지, 11(2), pp.117~125 (2000)